Clear Street analyst Bill Maughan reiterated a Buy rating and $6.60 price target on Century Therapeutics (NASDAQ: IPSC).The analyst comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE